###begin article-title 0
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
Genetic Variation in the Familial Mediterranean Fever Gene (MEFV) and Risk for Crohn's Disease and Ulcerative Colitis
###end article-title 0
###begin p 1
Conceived and designed the experiments: ACV CC GF TJH DF. Performed the experiments: ACV CC GF YR SB. Analyzed the data: ACV ML. Contributed reagents/materials/analysis tools: ML EL MSS ERN CL JB AB DG AC DL JDR IDRA GEW PR JS SV TJH DF. Wrote the paper: ACV ML DF.
###end p 1
###begin title 2
Background and Aims
###end title 2
###begin p 3
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 229 234 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 310 315 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 436 440 433 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
The familial Mediterranean fever (FMF) gene (MEFV) encodes pyrin, a major regulator of the inflammasome platform controlling caspase-1 activation and IL-1beta processing. Pyrin has been shown to interact with the gene product of NLRP3, NALP3/cryopyrin, also an important active member of the inflammasome. The NLRP3 region was recently reported to be associated with Crohn's disease (CD) susceptibility. We therefore sought to evaluate MEFV as an inflammatory bowel disease (IBD) susceptibility gene.
###end p 3
###begin title 4
Methodology and Results
###end title 4
###begin p 5
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 107 108 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 121 122 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 152 153 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 205 206 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 417 421 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 495 496 495 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 506 507 506 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 722 727 722 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D102D</italic>
###xml 738 743 738 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G138G</italic>
###xml 754 759 754 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A165A</italic>
###xml 829 833 829 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 895 896 895 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 907 908 907 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1151 1152 1151 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1162 1163 1162 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 1283 1288 1283 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 1418 1423 1418 1423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 1428 1432 1428 1432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 195 203 <span type="species:ncbi:9606">patients</span>
MEFV colonic mucosal gene expression was significantly increased in experimental colitis mice models (TNBS p<0.0003; DSS p<0.006), in biopsies from CD (p<0.02) and severe ulcerative colitis (UC) patients (p<0.008). Comprehensive genetic screening of the MEFV region in the Belgian exploratory sample set (440 CD trios, 137 UC trios, 239 CD cases, 96 UC cases, and 107 healthy controls) identified SNPs located in the MEFV 5' haplotype block that were significantly associated with UC (rs224217; p = 0.003; A allele frequency: 56% cases, 45% controls), while no CD associations were observed. Sequencing and subsequent genotyping of variants located in this associated haplotype block identified three synonymous variants (D102D/rs224225, G138G/rs224224, A165A/rs224223) and one non-synonymous variant (R202Q/rs224222) located in MEFV exon 2 that were significantly associated with UC (rs224222: p = 0.0005; A allele frequency: 32% in cases, 23% in controls). No consistent associations were observed in additional Canadian (256 CD trios, 91 UC trios) and Scottish (495 UC, 370 controls) sample sets. We note that rs224222 showed marginal association (p = 0.012; G allele frequency: 82% in cases, 70% in controls) in the Canadian sample, but with a different risk allele. None of the NLRP3 common variants were associated with UC in the Belgian-Canadian UC samples and no significant interactions were observed between NLRP3 and MEFV that could explain the observed flip-flop of the rs224222 risk allele.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
The differences in association levels observed between the sample sets may be a consequence of distinct founder effects or of the relative small sample size of the cohorts evaluated in this study. However, the results suggest that common variants in the MEFV region do not contribute to CD and UC susceptibility.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 280 283 280 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Podolsky1">[1]</xref>
###xml 572 575 572 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Barrett1">[2]</xref>
###xml 629 633 629 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 638 643 638 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 739 742 739 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Barrett1">[2]</xref>
###xml 777 782 777 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 884 887 884 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Villani1">[3]</xref>
###xml 945 948 945 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Duerr1">[4]</xref>
###xml 949 952 949 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Wellcome1">[9]</xref>
###xml 954 959 954 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 981 986 981 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIAS1</italic>
###xml 1127 1131 1127 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Ting1">[10]</xref>
###xml 1251 1255 1251 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Milhavet1">[11]</xref>
###xml 1481 1485 1481 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Ting1">[10]</xref>
###xml 1517 1522 1517 1522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 1702 1706 1702 1706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Ting1">[10]</xref>
###xml 1707 1711 1707 1711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Agostini1">[13]</xref>
###xml 1713 1718 1713 1718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 1967 1971 1964 1968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Mariathasan1">[12]</xref>
###xml 1972 1976 1969 1973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Martinon1">[15]</xref>
Crohn's disease (CD) and ulcerative colitis (UC) are multifactorial and heterogeneous, chronically relapsing inflammatory bowel diseases (IBD) that are thought to result from a dysregulated mucosal immune response to gut lumen bacterial antigens in a genetically susceptible host [1]. A recent meta-analysis of three large CD genome-wide association studies (GWAS) has reported that well-established associations with CD only accounts for approximately 20% of the genetic variance observed in CD, suggesting that additional genetic contributions have yet to be discovered [2]. Indeed, with the exception of variations within the NOD2 and IL23R genes, established susceptibility alleles have been reported to have relatively modest effects [2]. Using a candidate gene approach, NLRP3 (Chr.1q44; GenBank AF054176; OMIM 606416) was recently identified as a novel CD susceptibility locus [3] that had not been described in previously published GWAS [4]-[9]. NLRP3 (previously known as CIAS1) is part of the CATERPILLER (CARD (caspase recruitment domain), Transcription Enhancer, R (purine)-binding, Pyrin, Lots of Leucine Repeats) [10] gene family and mutations in some of these genes have been shown to result in severe auto-inflammatory diseases (AIDs) [11]. AIDs represent a spectrum of diseases characterized by recurrent episodes of seemingly unprovoked inflammation that, unlike autoimmune disorders, lack the production of high-titer auto-antibodies or antigen-specific T cells [10]. Gain-of-function mutations in NLRP3 are associated with three hereditary periodic fever syndromes: Muckle-Wells syndrome, familial cold autoinflammatory syndrome, and neonatal-onset multisystem inflammatory disease [10]-[13]. NLRP3 encodes NALP3 (also known as cryopyrin). This protein plays a key role in controlling the inflammasome, which is a critical molecular platform regulating caspase-1 activation and interleukin (IL)-1beta processing, two key mediators of inflammation [12]-[15].
###end p 9
###begin p 10
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 319 323 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Chae1">[16]</xref>
###xml 324 328 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Papin1">[18]</xref>
###xml 345 349 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 448 452 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Pras1">[19]</xref>
###xml 453 457 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Bernot1">[22]</xref>
Recently, the SPRY (also known as B30.2) domain of the protein pyrin, which is encoded by the MEFV gene (Chr.16p13.3; GenBank NM_000243; OMIM 608107), has been reported to interact with and modulate the activity of several inflammasome components, including NALP3/cryopyrin, caspase-1, and, its substrate, pro-IL-1beta [16]-[18]. Interestingly, MEFV missense mutations are implicated in the familial Mediterranean fever (FMF), which is another AID [19]-[22].
###end p 10
###begin p 11
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Lichtenberger1">[23]</xref>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-McDermott1">[24]</xref>
###xml 703 707 703 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Cattan1">[25]</xref>
###xml 708 712 708 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Fidder1">[26]</xref>
###xml 753 757 753 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 842 846 842 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Fidder2">[27]</xref>
###xml 847 851 847 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Sari1">[30]</xref>
###xml 628 636 <span type="species:ncbi:9606">patients</span>
###xml 833 841 <span type="species:ncbi:9606">patients</span>
Additional clinical and epidemiological evidence supported MEFV as a potential IBD candidate gene. IBD and FMF share common clinical and biologic features; they are both inflammatory disorders characterized by the same chronic relapsing behavior, infiltration by neutrophils at the site of injury, and abnormal regulation of apoptosis [23]-[24]. Moreover, FMF affects mainly ethnic groups surrounding the Mediterranean Sea (e.g. non-Ashkenazi Jews, Armenians, Turks, and Arabs) and two small cohort studies from that region have reported a higher prevalence of IBD, with particularly severe symptoms in FMF non-Ashkenazi Jewish patients, suggesting possible common underlying mechanisms of inflammation [25]-[26]. Additional studies have suggested that MEFV rare missense causative mutations have a potential modifying effect in IBD patients [27]-[30].
###end p 11
###begin p 12
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 314 318 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 394 398 394 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
This clinical and epidemiological evidence linking IBD to the MEFV gene, together with the co-localization of the MEFV and NLRP3 gene products (pyrin and NALP3, respectively) within the same signaling pathway, suggested that MEFV could also contribute to CD and/or UC susceptibility. We therefore explored whether MEFV expression was regulated in IBD experimental models of colitis and whether MEFV variants were associated with CD and/or UC susceptibility.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 101 109 <span type="species:ncbi:9606">patients</span>
1. MEFV expression is increased in IBD experimental models of colitis and in colonic mucosa from IBD patients
###end title 14
###begin p 15
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 129 133 129 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mefv</italic>
###xml 249 250 247 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 260 269 258 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007154-g001">Figure 1A</xref>
###xml 346 347 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 356 365 352 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007154-g001">Figure 1B</xref>
###xml 488 492 484 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 633 634 627 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 642 651 636 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007154-g001">Figure 1C</xref>
###xml 707 708 699 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 716 725 708 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007154-g001">Figure 1D</xref>
###xml 880 884 872 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 969 970 959 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 979 988 969 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007154-g001">Figure 1C</xref>
###xml 1025 1026 1013 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1035 1044 1023 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007154-g001">Figure 1D</xref>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 465 470 <span type="species:ncbi:9606">human</span>
###xml 567 575 <span type="species:ncbi:9606">patients</span>
###xml 670 678 <span type="species:ncbi:9606">patients</span>
###xml 834 838 <span type="species:ncbi:162683">Mayo</span>
###xml 1046 1054 <span type="species:ncbi:9606">patients</span>
To further support our candidate gene selection, we first evaluated MEFV expression in different models of experimental colitis. Mefv expression is significantly increased in trinitrobenzene sulfonic acid (TNBS)-induced (fold change  = 4.10+/-1.02; p<0.0003) (Figure 1A) and in dextran sulfate sodium (DSS)-induced (fold change = 131.74+/-44.14; p<0.006) (Figure 1B) colitis mice models as compared to colonic tissues from control mice (arbitrary baseline = 1). In human tissue biopsies, MEFV expression is significantly increased in ulcerated colonic mucosa from CD patients compared to healthy controls (fold change = 6.35+/-5.45; p<0.02) (Figure 1C), but not from UC patients (fold change = 2.50+/-1.90; p<0.27) (Figure 1D). However, stratification by severity of disease, as defined by the presence of endoscopic lesions (CD) and Mayo sub-endoscopic criteria (UC), shows that MEFV expression is upregulated in both severely affected CD (fold change = 12.58+/-5.11; p<0.001) (Figure 1C) and UC (fold change = 6.23+/-1.97; p<0.008) (Figure 1D) patients compared to healthy controls.
###end p 15
###begin title 16
Level of MEFV mRNA expression in inflamed colitis tissues compared to healthy controls.
###end title 16
###begin p 17
###xml 7 11 7 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 582 585 582 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 654 655 652 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 223 228 <span type="species:ncbi:9606">human</span>
(a, b) MEFV expression was assessed by quantitative real-time PCR in (a, b) healthy mice colons (n = 7), in colons from (a) TNBS-induced (n = 8) and (b) DSS-induced (n = 4) colitis mice models, as well as in (c, d) healthy human (n = 25), (c) CD (n = 16) and (d) UC (n = 17) colonic specimens. MEFV expression appeared to correlate with disease severity in both CD (c: 9 CD with mild inflammation and 7 CD with severe inflammation) and UC (d: 6 UC with mild inflammation, 7 UC with moderate inflammation and 4UC with severe inflammation) samples. (a-d) Expression was normalized to 18S gene expression and each bar represents the mean value+/-S.D. (*) = p<0.05 compared to healthy colonic specimens, considered as the arbitrary baseline = 1.
###end p 17
###begin title 18
2. MEFV mutations in exon 10 do not contribute to CD and UC susceptibility
###end title 18
###begin p 19
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 147 151 147 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 240 245 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M680I</italic>
###xml 258 263 258 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M694V</italic>
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M694I</italic>
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V726A</italic>
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Milhavet1">[11]</xref>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-The1">[20]</xref>
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Bernot1">[22]</xref>
###xml 492 497 492 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R652H</italic>
###xml 510 515 510 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M694V</italic>
###xml 532 537 532 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V726A</italic>
###xml 627 631 627 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 780 784 780 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Cattan1">[25]</xref>
###xml 785 789 785 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Sari1">[30]</xref>
###xml 366 374 <span type="species:ncbi:9606">patients</span>
###xml 382 390 <span type="species:ncbi:9606">patients</span>
###xml 446 454 <span type="species:ncbi:9606">patients</span>
###xml 771 779 <span type="species:ncbi:9606">patients</span>
FMF is thought to be secondary to missense mutations in MEFV. Although these mutations are found throughout the gene, five sequence alterations in MEFV represent the majority of FMF chromosomes, four of which are clustered in exon 10 (i.e. M680I/rs28940580, M694V/rs61752717, M694I/rs28940578, and V726A/rs28940579) [11], [20]-[22]. This exon was sequenced in 47 CD patients, 47 UC patients and 94 controls. Only three individuals (2 CD and 1 UC patients) carrying three different mutations (R652H/rs28940581, M694V/rs61752717, and V726A/rs28940579 respectively) were observed. None of the exon 10 variants could link IBD with MEFV. The low frequency of these observed mutations confirms previous reports studying the prevalence and association of these mutations in IBD patients [25]-[30].
###end p 19
###begin title 20
3. Common SNPs located in MEFV 5' region are significantly associated with IBD in the Belgian exploratory sample set
###end title 20
###begin p 21
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 204 208 204 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-deBakker1">[31]</xref>
###xml 356 357 356 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 355 357 355 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 593 597 589 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 662 669 658 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t001">Table 1</xref>
We subsequently sought to evaluate MEFV common variants for their association with IBD. We first investigated a 98 kb region spanning chromosome 16p13.3 (3220975-3318978) (NCBI Build 35, hg17), including MEFV (14.6 kb). A pairwise tagging approach [31] was used to select single nucleotide polymorphisms (SNPs), using data from HapMap Public Release #22 (r2>/=0.8) (minor allele frequency (MAF) >/=0.05). The SNP panel was enriched with SNPs located in functional domains, as well as with SNPs selected from dbSNP Build126 in regions with lower coverage. A total of 30 informative SNPs in the MEFV region were genotyped in 440 Belgian CD trios and 137 UC trios (Table 1).
###end p 21
###begin title 22
Subjects examined as part of the MEFV candidate gene study.
###end title 22
###begin p 23
C/C refers to case control sample set.
###end p 23
###begin p 24
Includes 27 CD trios and 13 UC trios of Jewish ancestry.
###end p 24
###begin p 25
Includes 24 CD trios and 10 UC trios of Jewish ancestry; includes also 15 non-European probands, which were excluded from the analysis.
###end p 25
###begin p 26
Includes 1 UC case of Jewish ancestry; includes also 14 cases and 11 controls of non-European descent, which were excluded from the analysis.
###end p 26
###begin p 27
###xml 23 27 23 27 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Aldea1">[32]</xref>
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 149 157 149 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007154-g002">Figure 2</xref>
###xml 208 212 208 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 249 255 249 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF263</italic>
###xml 257 262 257 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIGD7</italic>
###xml 264 270 264 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF75A</italic>
###xml 300 308 300 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AK096958</italic>
###xml 340 344 340 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 378 382 378 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 447 453 447 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF200</italic>
###xml 455 463 455 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007154-g002">Figure 2</xref>
As previously reported [32], we observed two regions of high linkage disequilirium (LD) separated by a recombination "hotspot" within MEFV intron 2 (Figure 2). The 5' haplotype block includes the promoter to MEFV intron 2 region, three known genes (ZNF263, TIGD7, ZNF75A), and one hypothetical gene (AK096958). The 3' haplotype block spans MEFV intron 2 to the 3' UTR region of MEFV, as well as the region encompassing the promoter to intron 4 of ZNF200 (Figure 2).
###end p 27
###begin title 28
Exploratory phase association results of the SNP panel screened in the combined Belgian CD and UC trios sample sets.
###end title 28
###begin p 29
###xml 167 169 167 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D'</italic>
###xml 202 203 202 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 201 203 201 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 511 512 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Shown above are the SNPs with their positions in the genes and the LD structure between them. SNPs in red are exonic. The upper left portion of the coloured matrix is D' and the lower right portion is r2. Data for the first SNP is represented on the left column and the bottom row of the matrix. In the lower panel are reported the results from association analysis of the Belgian CD (a), and the Belgian UC (b) samples. Level of significance can be found on the scale located at the bottom left of the figure. P value of individual alleles are reported, where the symbols represent the associated allele (black triangle down = T, * = C, black triangle = A, diamond = G) and the color scheme represents the value of the LD measures and the allele frequency.
###end p 29
###begin p 30
###xml 91 96 91 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">major</italic>
###xml 247 251 247 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 310 311 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 314 315 314 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 334 335 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 338 339 338 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 358 359 358 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 362 363 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 383 384 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 387 388 387 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 447 456 447 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007154-g002">Figure 2A</xref>
###xml 458 466 458 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007154.s004">Table S1</xref>
The analysis of Belgian CD trios revealed only nominally significant associations with the major alleles (i.e. allele frequency in controls >50%) of four SNPs, three of which are located in the haplotype block encompassing the region covering the MEFV promoter to intron 2 and its 5' flanking region (rs182674(A): p = 0.029; rs224217(G): p = 0.052; rs224231(G); p = 0.039; rs6501170(T): p = 0.016; the risk nucleotides are indicated in brackets) (Figure 2A, Table S1).
###end p 30
###begin p 31
###xml 75 76 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 132 133 132 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 145 146 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 158 159 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 171 172 171 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 184 185 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 197 198 197 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 210 211 210 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 227 228 227 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 296 305 296 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007154-g002">Figure 2B</xref>
###xml 307 315 307 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007154.s004">Table S1</xref>
###xml 533 542 533 542 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">corrected</sub>
###xml 532 542 532 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p<sub>corrected</sub></italic>
###xml 604 611 604 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 705 706 705 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 735 736 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 778 785 778 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t001">Table 1</xref>
The analysis of Belgian UC trios revealed significant associations (lowest p = 0.0007 for rs224217) with eight SNPs (i.e. rs1149483(C), rs224243(T), rs224231(A), rs224230(A), rs224226(G), rs224225(C), rs182674(G), and rs224217(A)) located in that same 5' haplotype block also associated with CD (Figure 2B, Table S1). We note that the risk alleles differ for those SNPs associated with both CD and UC. Contrary to the CD associations, the UC associations remained significant after allowing for the total number of tests performed (pcorrected = 0.018 based on 1000 random permutations in 2 diseases; see Methods). These associations with UC were also significant across the two Belgian Centers (rs224217: p = 0.038 [Center 1: Leuven]; p = 0.0008 [Center 2: Liege]) described in Table 1.
###end p 31
###begin title 32
4. Sequencing of coding and promoter regions of genes located in the associated 5' haplotype block
###end title 32
###begin p 33
###xml 251 259 251 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AK096958</italic>
###xml 261 267 261 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF263</italic>
###xml 269 274 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIGD7</italic>
###xml 276 282 276 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF75A</italic>
###xml 295 299 295 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 518 525 518 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t002">Table 2</xref>
###xml 318 326 <span type="species:ncbi:9606">patients</span>
###xml 334 342 <span type="species:ncbi:9606">patients</span>
Following the identification of the association signals with CD and UC in the 5' haplotype block, we sequenced the exons and promoter regions (i.e. 2 kb upstream) of all genes located within this region to exclude the involvement of other genes (i.e. AK096958, ZNF263, TIGD7, ZNF75A) aside from MEFV. A total of 10 UC patients, 10 CD patients and 10 healthy controls were sequenced, and 9 synonymous and 9 non-synonymous variants were identified. A detailed description of all observed coding variants can be found in Table 2.
###end p 33
###begin title 34
Coding variants uncovered in the MEFV 5' haplotype block.
###end title 34
###begin p 35
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIGD7</italic>
###xml 135 141 135 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF263</italic>
###xml 155 163 155 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AK096958</italic>
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
According to the cDNA coding sequence, with +1 from the A of the initiating ATG. Reference sequences are NM_033208 (TIGD7), NM_005741 (ZNF263), NC_000016 (AK096958), and NM_000243 (MEFV).
###end p 35
###begin p 36
dbSNP:
###end p 36
###begin title 37
5. Augmenting the sample size: MEFV common SNPs do not contribute to CD and UC susceptibility
###end title 37
###begin title 38
5.1 The Belgian samples
###end title 38
###begin p 39
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-deBakker1">[31]</xref>
###xml 662 669 662 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t002">Table 2</xref>
To further validate the Belgian association results, we first augmented the sample size by genotyping additional unrelated Belgian cases and controls (239 CD, 96 UC and 107 shared controls), and combining them with the 440 CD and 137 UC trios previously genotyped. The cases and controls were genotyped for 12 of the 30 exploratory set of SNPs, which were chosen using a pairwise tagging approach [31] to remove the redundancy among the genotyped markers, given the high level of LD between them. Additionally, all Belgian case-control and trio samples were genotyped for the non-synonymous variants observed in the sequencing experiment, which are described in Table 2.
###end p 39
###begin p 40
###xml 162 169 162 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t003">Table 3</xref>
###xml 276 283 276 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t002">Table 2</xref>
###xml 324 331 324 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t003">Table 3</xref>
Increasing the sample size in the combined Belgian CD case-control-trio analyses did not reveal more significant associations between the 12 tagging SNPs and CD (Table 3). Moreover, no significant associations were observed between all non-synonymous coding SNPs described in Table 2 and the combined CD Belgian sample set (Table 3).
###end p 40
###begin title 41
Association results of tagging SNPs and MEFV exon 2 coding SNPs in CD sample sets.
###end title 41
###begin p 42
Includes 440 CD trios, 239 CD cases, and 107 healthy controls.
###end p 42
###begin p 43
Includes 256 CD trios.
###end p 43
###begin p 44
Includes 696 CD trios, 239 CD cases, and 107 healthy controls.
###end p 44
###begin p 45
Alleles shown are the alleles seen more frequently in the cases than in the controls.
###end p 45
###begin p 46
###xml 202 209 202 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t004">Table 4</xref>
###xml 276 283 276 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t002">Table 2</xref>
###xml 326 331 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C310S</italic>
###xml 406 410 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26Q</italic>
###xml 425 430 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V534I</italic>
###xml 461 466 461 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N248H</italic>
###xml 573 577 573 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 683 687 683 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 696 701 696 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D102D</italic>
###xml 711 712 711 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 715 720 715 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G138G</italic>
###xml 730 731 730 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 734 739 734 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A165A</italic>
###xml 749 750 749 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 796 797 796 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 809 816 809 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t004">Table 4</xref>
###xml 876 877 876 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 875 877 875 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 929 930 929 930 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 928 930 928 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 940 949 940 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007154.s001">Figure S1</xref>
###xml 989 994 989 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R202Q</italic>
###xml 1047 1048 1047 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1059 1060 1059 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1209 1210 1209 1210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1208 1210 1208 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 1255 1256 1255 1256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1254 1256 1254 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 1266 1275 1266 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007154.s001">Figure S1</xref>
In the combined Belgian UC case-control-trio analyses, the association significance levels observed with the 12 tagging SNPs were similar to the ones observed in the analysis focussing solely on trios (Table 4). The UC association analysis of the non-synonymous variants from Table 2 revealed no significant associations with C310S (previously genotyped rs220379), as well as with the rare coding variants R26Q (3 carriers), V534I/rs34236132 (11 carriers), and N248H (8 carriers). Similarly, no significant associations with coding variants located in the 3' end region of MEFV were detected. However, significant associations were observed with three synonymous variants located in MEFV exon 2 (D102D/rs224225(C), G138G/rs224224(G), A165A/rs224223(A)) and UC in the Belgian combined sample set (p = 0.0015) (Table 4); these three variants are in perfect LD with each other (r2 = 1.00) and in high LD with tagging SNP rs224217 (r2 = 0.85) (Figure S1). Additionally, the non-synonymous SNP R202Q/rs224222 was also significantly associated with UC (p = 0.0005; A allele frequency: 32% cases, 23% controls) in the Belgian samples. The variant rs224222 is in low LD with the three synonymous variants of exon 2 (r2 = 0.38) and with the tagging SNP rs224217 (r2 = 0.33) (Figure S1).
###end p 46
###begin title 47
Association results of tagging SNPs and MEFV exon 2 coding SNPs in the UC sample sets.
###end title 47
###begin p 48
Includes 137 UC trios, 96 UC cases, and 107 healthy controls.
###end p 48
###begin p 49
Includes 91 UC trios.
###end p 49
###begin p 50
Includes 495 UC cases and 370 healthy controls.
###end p 50
###begin p 51
Includes 228 UC trios, 591 UC cases, and 477 healthy controls.
###end p 51
###begin p 52
Alleles shown are the alleles seen more frequently in the cases than in the controls.
###end p 52
###begin p 53
###xml 151 155 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 319 326 319 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t001">Table 1</xref>
To assess the reproducibility of these results, we subsequently evaluated the association of the same 12 tagging SNPs and the 4 coding SNPs located in MEFV exon 2 region (i.e. rs224225, rs224224, rs224223, and rs224222) in additional samples from Canada (256 CD trios, 91 UC trios) and Scotland (495 UC, 370 controls) (Table 1).
###end p 53
###begin title 54
5.2 The Canadian samples
###end title 54
###begin p 55
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 170 171 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 216 223 216 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t003">Table 3</xref>
###xml 387 394 387 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t003">Table 3</xref>
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
In the Canadian CD sample set, only the minor allele of tagging SNP rs224230, located in the 5' flanking region of MEFV, was significantly associated with CD (p = 0.044; G allele frequency: 40% cases, 33% controls) (Table 3). None of the 16 SNPs were consistently replicated across the Belgian and Canadian CD sample sets, or in the combined analysis of the Belgian-Canadian CD samples (Table 3), supporting the exclusion of the MEFV region as a risk factor contributing to CD susceptibility.
###end p 55
###begin p 56
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 148 149 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 250 251 250 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 261 262 261 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 317 324 317 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t004">Table 4</xref>
###xml 388 389 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 452 453 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 588 595 588 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t004">Table 4</xref>
###xml 715 722 715 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t004">Table 4</xref>
###xml 724 733 724 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007154-g002">Figure 2B</xref>
###xml 735 743 735 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007154.s004">Table S1</xref>
In the Canadian UC sample set, analysis of individual tagging SNPs uncovered one nominally significant association in the MEFV 5' region (rs220379: p = 0.046; G allele frequency: 81% cases, 70% controls) and one association with coding SNP rs224222 (p = 0.012; G allele frequency: 82% cases, 70% controls) in exon 2 (Table 4). Contrary to the association in the Belgian samples where the A allele of rs224222 was associated with UC susceptibility, the G allele is associated with UC in the Canadian samples, and no associations were observed with the three synonymous variants of exon 2 (Table 4). None of these results replicated the initial significant findings observed in the Belgian exploratory UC sample set (Table 4, Figure 2B, Table S1).
###end p 56
###begin title 57
5.3 The Scottish samples
###end title 57
###begin p 58
###xml 63 70 63 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t001">Table 1</xref>
###xml 82 83 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 126 130 126 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 178 179 178 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 189 190 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 353 360 353 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t004">Table 4</xref>
###xml 471 478 471 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t004">Table 4</xref>
In the third UC case-control cohort from Scotland (Edinburgh) (Table 1), only the A allele of tagging SNP rs224215 located in MEFV intron 2 was significantly associated with UC (p = 0.041; A allele frequency: 63% cases, 58% controls). None of the associations observed in the Belgian and Canadian UC analyses were replicated in the Scottish sample set (Table 4). No SNPs were significantly associated in the combined analysis of all Belgian-Canadian-Scottish UC samples (Table 4).
###end p 58
###begin title 59
6. Rare variants in MEFV exon 2
###end title 59
###begin p 60
###xml 231 239 231 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007154.s005">Table S2</xref>
###xml 351 355 351 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 608 609 608 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 681 682 681 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 700 701 700 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 910 911 910 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Interestingly, sequencing of exon 2 in all cohorts, primarily as a means to genotype the four exon 2 coding variants (i.e. rs224225, rs224224, rs224223, and rs224222), revealed 15 new rare non-synonymous and 8 synonymous variants (Table S2). Four of them are located on predicted CpG dinucleotides, demonstrating the high potential variability of the MEFV exon 2 region. Although these rare variants alone cannot explain the rs224222 associated region, it is interesting to note that of the 8 UC parents carrying a rare mutation, 7 out of 8 transmitted the mutation to affected probands (binomial exact test p = 0.07); 3 of these 8 UC parents transmitted the rs224222 risk allele "A" to UC probands (p = 1.000). Furthermore, 5 UC sporadic cases compared to 3 unaffected individuals carry a rare mutation, and 4 out of the 7 CD parents carrying a rare mutation transmitted the rare allele to affected probands (p = 1.000).
###end p 60
###begin title 61
7. No epistatic interactions are observed between NLRP3 and MEFV in the CD and UC combined Belgian-Canadian sample set
###end title 61
###begin p 62
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 101 104 101 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Villani1">[3]</xref>
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 136 140 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 291 295 291 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 317 322 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 360 364 360 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 521 526 521 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 533 536 533 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Villani1">[3]</xref>
###xml 561 565 561 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 621 626 621 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 713 722 713 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007154.s002">Figure S2</xref>
Based on the identification of six common SNPs in the NLRP3 region contributing to CD susceptibility [3] and reports that the NLRP3 and MEFV gene products interact with each other and are involved in similar pathways, we sought to evaluate whether possible gene-gene interaction between the MEFV tagging SNPs and the NLRP3 six common SNPs could have masked an MEFV contribution to CD susceptibility. Using the Belgian-Canadian 639 CD trios, 239 CD cases, and 107 healthy controls commonly genotyped in this study and the NLRP3 study [3], stratified analyses of MEFV variants conditional on each individual's genotypes at NLRP3 variants did not provide evidence of associations under the possibility of epistasis (Figure S2).
###end p 62
###begin p 63
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
In addition, we also evaluated the association of these six NLRP3 SNPs in the Belgian and Canadian UC sample sets and subsequently assessed whether gene-gene interactions in the combined Belgian-Canadian UC samples could explain the flip-flop phenomenon observed with rs224222, where different alleles were associated with UC in the Belgian and Canadian samples.
###end p 63
###begin p 64
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 225 233 225 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007154.s006">Table S3</xref>
###xml 309 314 309 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 316 325 316 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007154.s003">Figure S3</xref>
###xml 464 468 464 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 520 525 520 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLPR3</italic>
###xml 607 616 607 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007154.s003">Figure S3</xref>
###xml 727 731 727 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
No significant associations were observed between the six NLRP3 SNPs and UC in the Belgian, Canadian, and combined Belgian-Canadian sample sets when using the commonly genotyped 228 UC trios, 96 UC, and 107 healthy controls (Table S3), nor were any significant interactions found between rs224222 and SNPs in NLRP3 (Figure S3). Hence, multi-locus effects between the two genes do not explain the observed flip-flop. Additionally, the levels of association for the MEFV SNPs conditional on each individual's genotypes at NLPR3 are in the same order of magnitude than the unconditional levels of association (Figure S3), indicating that epistasis between the two genes is not a mechanism that would be a regulator of the risk of MEFV on UC.
###end p 64
###begin title 65
Discussion
###end title 65
###begin p 66
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 378 382 378 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mefv</italic>
###xml 767 771 767 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 869 873 869 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 883 887 883 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Aldea1">[32]</xref>
###xml 965 969 965 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 342 347 <span type="species:ncbi:9606">human</span>
###xml 468 472 <span type="species:ncbi:10090">mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 694 702 <span type="species:ncbi:9606">patients</span>
Genes, such as MEFV, in which mutations lead to severe systemic inflammatory diseases, like the AIDs, play a critical role in the control of inflammation and may represent potential candidates for the onset of chronic inflammatory disorders like CD and UC. To further support our candidate gene selection, we integrated results from mice and human colonic expression studies of MEFV. We found Mefv expression to be significantly increased in both TNBS-induced colitis mice model, which mimics CD-like intestinal inflammation, and in DSS-induced colitis mice model, which mimics UC-like intestinal inflammation. Gene expression was also increased in inflamed colonic tissues from both CD and UC patients, correlating with severity of inflammation. Fine mapping of the MEFV region revealed two haplotype-blocks with a previously reported recombination hotspot located in MEFV intron 2 [32]. In our exploratory phase, we report associations of variants located in the MEFV 5' region with both CD and UC in Belgian samples, yet we failed to subsequently validate these associations in the Canadian and Scottish additional sample sets.
###end p 66
###begin p 67
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 157 161 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Mariathasan1">[12]</xref>
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Papin1">[18]</xref>
###xml 305 309 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Cattan1">[25]</xref>
###xml 310 314 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Karban1">[28]</xref>
###xml 352 356 352 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 594 598 594 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 693 697 693 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 753 758 753 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 806 809 806 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Villani1">[3]</xref>
###xml 840 845 840 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 850 854 850 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 962 966 962 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Chae1">[16]</xref>
###xml 967 971 967 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Papin1">[18]</xref>
###xml 1051 1055 1051 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 1060 1065 1060 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 1131 1135 1131 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 1329 1333 1329 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 1382 1386 1382 1386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 1527 1531 1527 1531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Cattan1">[25]</xref>
###xml 1532 1536 1532 1536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Karban1">[28]</xref>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
The up-regulation of MEFV gene expression in the CD and UC patients, as well as in the mouse models, can be explained by the broad involvement of pyrin, the MEFV encoded protein, in the regulation of the inflammasome molecular platform and the inflammatory process [12]-[18]. Previously published studies [25]-[28] have excluded the involvement of the MEFV gene in CD pathogenesis by looking at specific rare FMF missense causative mutations clustered in exons 2 and 10 in a relatively small number of CD cases. Unlike these previous reports, we carried out a thorough genetic screening of the MEFV region in two large CD sample sets and observed no association between common variants in the MEFV region and CD. Also, given that common variants in the NLRP3 region have previously been associated with CD [3] and that the gene products of NLRP3 and MEFV (i.e. NALP3 and pyrin, respectively) are known to interact together in the inflammasome molecular platform [16]-[18], we also perform gene-gene interaction analysis between common variants in the MEFV and NLRP3 region to assess whether such interactions could have masked the MEFV contribution to CD pathogenesis. Since no interactions were observed when looking at the large Belgian-Canadian CD sample set and no common variants were consistently associated with CD in the MEFV region, we conclude that common variants in the MEFV region are unlikely to contribute to CD susceptibility, which is in agreement with previous studies looking at rare FMF causative mutations [25]-[28].
###end p 67
###begin p 68
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 184 188 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 380 384 380 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
Upon the observation of significant associations between SNPs located in the 5' block region of MEFV and UC in the exploratory phase, we excluded possible coding risk variants and non-MEFV genes located in this 5' block by sequencing all the exonic and promoter regions of the five genes in the region and genotyping the uncovered non-synonymous variants. Only coding SNPs within MEFV exon 2 (i.e. rs224225, rs224224, rs224223, and rs224222) were significantly associated with UC in the Belgian samples. However, none of the synonymous variants were associated with UC in the Canadian samples, and we observed opposite rs224222 allele association with UC in the Belgian and Canadian cohorts, suggesting that rs224222 was unlikely to be a causative variant contributing to UC susceptibility.
###end p 68
###begin p 69
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Lin1">[33]</xref>
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Zaykin1">[34]</xref>
###xml 603 607 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Lin1">[33]</xref>
###xml 608 612 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Zaykin1">[34]</xref>
###xml 721 725 721 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 849 853 849 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Lin1">[33]</xref>
###xml 964 970 964 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1238 1242 1238 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Lin1">[33]</xref>
###xml 1302 1306 1302 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 1315 1320 1315 1320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 1395 1400 1395 1400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 1452 1455 1452 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Villani1">[3]</xref>
###xml 1565 1570 1565 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 1609 1613 1609 1613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 1664 1668 1664 1668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 1738 1743 1738 1743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
Such flip-flop associations observed with rs224222 in samples of similar ethnical origins are often regarded as spurious findings, leading to a number of different possible explanations for such observations, like a difference in genetic background and environment [33]-[34]. For example, when attempting to replicate the association of a non-causal allele in LD with the causative variant in two different populations, as it is the case with our Belgian and Canadian sample sets, a difference in LD patterns between the populations could result in inconsistent associations observed across sample sets [33]-[34]. This is not our case, as the Belgian and Canadian UC sample sets displayed very similar LD patterns in the MEFV region (data not shown). This inverse association could also indicate the presence of interactions with another risk locus [33]. Complex traits usually result from the interplay of several genetic risk loci and environmental factors. Lin et al. have shown that performing single marker analysis without considering the possibility of other genetic risk loci or environmental risk factors correlating with the candidate locus, or the possibility of a multi-locus effect, could also lead to flip-flop associations [33]. To assess this latter possibility, since we knew that the MEFV and the NLRP3 gene product interacted with each other, we genotyped the six SNPs in the NLRP3 region that had been previously associated with CD [3] in both the Belgian and Canadian UC sample sets and performed gene-gene interaction analysis using these six NLRP3 SNPs and the 16 SNPs genotyped in the MEFV region (i.e. 12 tagging SNPs and 4 coding SNPs in MEFV exon 2 region). As no significant interactions were observed between NLRP3 variants and rs224222, the basis behind the inverse allele associations observed with rs224222 remains unresolved.
###end p 69
###begin p 70
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 154 162 <span type="species:ncbi:9606">patients</span>
Although we have not mapped a causative variant in MEFV exon 2, we observed that this exon is enriched with rare mutations that tend to be transmitted to patients, indicating not only the allelic heterogeneity of that region but also its biological importance. However, the distribution of the rs224222 risk allele was not significantly skewed in carriers of these rare mutations.
###end p 70
###begin p 71
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 226 230 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 282 286 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CGAA</italic>
###xml 287 288 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 435 439 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Aldea1">[32]</xref>
###xml 504 508 504 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 566 570 566 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 588 592 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Giaglis1">[29]</xref>
###xml 757 761 757 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TACG</italic>
###xml 1041 1045 1041 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Giaglis1">[29]</xref>
###xml 1163 1167 1163 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 1210 1214 1210 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Day1">[35]</xref>
###xml 1299 1303 1299 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 1411 1415 1411 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 965 973 <span type="species:ncbi:9606">patients</span>
###xml 978 986 <span type="species:ncbi:9606">patients</span>
Of interest, several other groups have reported the contribution of MEFV and SNPs in the same 5' region to the susceptibility of UC and other chronic inflammatory disorder. For example, the alleles of the 4 coding variants of MEFV exon 2 (rs224225, rs224224, rs224223 and rs224222: CGAA/G) that are significantly associated with UC in this study have also been associated with FMF causative rare mutations in Mediterranean populations [32]. A study conducted in a Greek population, focusing precisely on MEFV exons 2 and 10, reported an association between UC and a MEFV exon 2 haplotype [29]. Yet, the FMF causative mutations were reported to be associated with the other alleles of the exon 2 coding variants (i.e. rs224225, rs224224, rs224223, rs224222: TACG) in this population. This latter difference in association could be a consequence of a distinct founder effect or of the relatively small sample size evaluated in their study, which comprised only 25 UC patients, 28 patients with rheumatoid arthritis, and 65 healthy individuals [29]. In agreement with our preliminary UC association results, another study reported the association of six SNPs in the MEFV region with juvenile idiopathic arthritis [35]. Among these SNPs, three of them (i.e. rs224217, rs224225, rs224223) located in the MEFV 5' region were also associated in our study. Although of modest size, these studies point towards the same MEFV region as being involved in inflammatory processes.
###end p 71
###begin p 72
###xml 696 700 696 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
Despite the above-mentioned studies, our UC exploratory association results need to be interpreted with caution. Indeed, the associations were observed in two relatively small UC sample sets (totaling 228 Belgian-Canadian trios, 96 UC cases and 107 healthy controls), and no associations were replicated in our largest UC sample set from Scotland (495 UC cases and 370 controls). Additionally, in the combined analyses of all sample sets, we observed no SNPs significantly associated with UC. Overall, given the lack of consistent replication across all our screened sample sets and the lack of SNP associations in the largest sample set (i.e. combined analysis of all samples), we conclude that MEFV is unlikely to contribute to UC susceptibility.
###end p 72
###begin p 73
###xml 494 501 494 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t005">Table 5</xref>
###xml 664 668 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Silverberg1">[36]</xref>
###xml 1247 1254 1247 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t005">Table 5</xref>
###xml 739 747 <span type="species:ncbi:9606">patients</span>
###xml 888 896 <span type="species:ncbi:9606">patients</span>
In addition to the size of the sample sets, another possible explanation for the lack of replication may originate from a difference in demographic and clinical characteristics of the UC samples studied. Although no specific genotype-phenotype associations were detected (data not shown), it is worth mentioning that while the mean age of onset of the probands of Belgian and Canadian UC trios is closer to 25 years old, the average age is approximately 40 for the Liege and Scottish UC cases (Table 5). Unlike CD where distinct categories of age of onset have been established by the Montreal classification (i.e. below 16, between 17-40, and above 40 years old) [36], such standards do not currently exist for UC. It is possible that UC patients with later age of onset have different risk factors involved than those individuals with earlier disease presentation. Such a difference in patients' age of onset could perhaps explain the lack of replication. Other differences in clinical subtype distribution in each case group, both UC and CD, may have also contributed to the lack of replication; unfortunately, no definitive conclusions may be reached since detailed information for some of the Centers that provided the samples is incomplete (Table 5).
###end p 73
###begin title 74
Demographic and clinical characteristics.
###end title 74
###begin p 75
Phenotypic information is not available for healthy controls from Liege.
###end p 75
###begin p 76
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 83 86 83 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Villani1">[3]</xref>
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 186 190 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Cho1">[37]</xref>
###xml 220 225 220 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 288 292 288 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 297 302 297 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 343 347 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Ting1">[10]</xref>
###xml 393 398 393 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 465 469 465 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 474 479 474 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 688 691 685 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Villani1">[3]</xref>
###xml 693 697 690 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Li1">[38]</xref>
###xml 698 702 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-vanBeelen1">[41]</xref>
###xml 739 743 736 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRGM</italic>
###xml 748 755 745 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG16L1</italic>
###xml 801 805 798 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Fisher1">[42]</xref>
###xml 806 810 803 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Franke1">[43]</xref>
###xml 1167 1171 1164 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Cho1">[37]</xref>
###xml 1173 1177 1170 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Fuss1">[44]</xref>
###xml 1178 1182 1175 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Plevy1">[45]</xref>
###xml 1249 1254 1246 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 1259 1263 1256 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 1124 1132 <span type="species:ncbi:9606">patients</span>
This is also the first report evaluating the six NLRP3 variants associated with CD [3] in a UC sample set. Interestingly, as is the case for the NOD2 mutations associated uniquely to CD [37], no associations between the NLRP3 variants and UC were observed. Given the similarities between NOD2 and NLRP3, both members of the CATERPILLER family [10], and the above results, we conclude that the NLRP3 association is likely to be specific to CD. Both gene products of NOD2 and NLRP3 play central roles in intracellular bacterial sensing and the CD associated variants of both genes were reported to result in a loss-of-function phenotype characterized by a decrease in secretion of IL-1beta [3], [38]-[41]. Interestingly, the autophagy genes IRGM and ATG16L1 have also been associated specifically to CD [42]-[43]. These results suggest that alterations in the intracellular sensing and processing of bacteria may constitute a central feature specific to the pathogenesis of CD, and that such primary defect in CD could result in the compensatory increase in the activity of Th1 cells that is observed in the lamina propria of patients with CD, but not in those with UC [37], [44]-[45]. We conclude that two of the key regulators of the inflammasomes, NLRP3 and MEFV, do not seem to contribute to UC susceptibility.
###end p 76
###begin p 77
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 133 137 133 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Ting1">[10]</xref>
###xml 325 329 325 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Mariathasan1">[12]</xref>
###xml 330 334 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Papin1">[18]</xref>
###xml 389 394 389 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 421 424 421 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Villani1">[3]</xref>
###xml 539 543 539 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 624 628 624 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 633 638 633 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 687 691 687 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
Several factors prompted us to hypothesize that MEFV could equally well be implicated in CD and UC susceptibility: mutations in both MEFV and NLRP3 cause auto-inflammatory diseases, these two genes encode for pyrin domain containing-proteins [10] that participate in the same shared signaling pathway (i.e. the inflammasome) [12]-[18], and the recent description of common variants in the NLRP3 region associated with CD [3]. However, our results suggests otherwise since we observed no consistent associations with common variants in the MEFV region across all our screened sample sets and no epistatic interaction between MEFV and NLRP3 variants. We thus conclude that variants in the MEFV region are unlikely to contribute to CD and UC susceptibility.
###end p 77
###begin title 78
Materials and Methods
###end title 78
###begin title 79
Ethics statement
###end title 79
###begin p 80
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 276 281 <span type="species:ncbi:9606">human</span>
###xml 494 499 <span type="species:ncbi:9606">human</span>
All research involving mice were handled according to institutionally recommended animal care guidelines and all experiments were approved by the Animal Studies Ethics Committee of McGill University. The McGill University Health Centre Institutional Review Board approved the human expression study of colonic biopsy specimens and written informed consent was obtained from all participating subjects. The local Institutional Review Board of each Institution that sent DNA samples approved the human genetic study, and written informed consent was obtained from all participating subjects.
###end p 80
###begin title 81
Tissue collection
###end title 81
###begin title 82
Animal experiments
###end title 82
###begin p 83
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Neurath1">[46]</xref>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Okayasu1">[47]</xref>
###xml 455 476 455 476 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Human tissue biopsies</underline>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 455 460 <span type="species:ncbi:9606">Human</span>
###xml 525 533 <span type="species:ncbi:9606">patients</span>
###xml 621 629 <span type="species:ncbi:9606">patients</span>
###xml 662 666 <span type="species:ncbi:162683">Mayo</span>
###xml 701 709 <span type="species:ncbi:9606">patients</span>
Male BALB/c mice (between 6 and 8 weeks of age), obtained from Charles River Laboratory (St-Constant, Quebec, Canada), were maintained under conventional housing conditions. Colitis was either induced by rectal instillation of 2.5 mg of trinitrobenzene sulfonic acid (TNBS) (Sigma Aldrich Canada Ltd., Ontario, Canada) or mice were fed with 5% dextran sulfate sodium (DSS) (MP Biomedicals, OH, USA) using modified protocols previously reported [46]-[47]. Human tissue biopsies: Colonic biopsy specimens were obtained from CD patients in ulcerated (severe involvement) and non-ulcerated (mild involvement) mucosa, from UC patients in inflamed areas as defined by Mayo sub-endoscopic criteria, and from patients who underwent colorectal cancer screening (CD n = 16; UC n = 17; Controls n = 25).
###end p 83
###begin title 84
RNA extraction and real-time quantitative PCR
###end title 84
###begin p 85
###xml 400 404 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mefv</italic>
###xml 427 431 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 448 451 448 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 583 587 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Holland1">[48]</xref>
###xml 311 316 <span type="species:ncbi:9606">human</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
###xml 421 426 <span type="species:ncbi:9606">human</span>
###xml 732 736 <span type="species:ncbi:10090">mice</span>
###xml 741 746 <span type="species:ncbi:9606">human</span>
Biopsies preserved in RNALater (Qiagen, Ontario, Canada) were homogenized and total RNA was extracted using TRIZOL (Invitrogen, Ontario, Canada). First strand cDNA was synthesized using the cDNA Archive Kit (Applied Biosystems (ABI), CA, USA) with MultiScribe reverse transcriptase and random primers. For both human and mice, primers and probes were ordered from Assay-on-demand ABI catalogue (mice Mefv: Mm00490260_gl; human MEFV: Hs00165145_ml; 18S: 4319413E). Quantitative real-time PCR was performed using ABI prism 7900 sequence detection system based on the 5' nuclease assay [48], and quantified using ABI's comparative Ct method. Statistical analyses were performed using the Wilcoxon Signed Ranks test to evaluate tissue (mice and human) expression differences (SPSS, Version 11.5, USA).
###end p 85
###begin title 86
Study populations
###end title 86
###begin p 87
###xml 115 123 115 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t001">Tables 1</xref>
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t005">5</xref>
###xml 477 481 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Silverberg1">[36]</xref>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-LennardJones1">[49]</xref>
###xml 715 718 715 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Podolsky1">[1]</xref>
###xml 720 724 720 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Silverberg1">[36]</xref>
###xml 726 730 726 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-LennardJones1">[49]</xref>
###xml 232 240 <span type="species:ncbi:9606">patients</span>
###xml 493 501 <span type="species:ncbi:9606">patients</span>
Three main sample sets, coming from 5 different Centers, were analyzed in this study (see detailed descriptions in Tables 1 and 5), comprising a total of 696 CD trios, 228 UC trios, 239 CD cases, 591 UC cases, and 477 controls. All patients were recruited through specialized hospitals, academic centres, and practitioners. Inflammatory bowel disease (IBD) specialists involved in this study confirmed the diagnosis of CD and UC using standard criteria further described below [36], [49], and patients were excluded from the study in the case of doubtful diagnosis. In all the participating Centers, the diagnosis of IBD was made after fulfilling standard clinical, radiological, endoscopic, and pathology criteria [1], [36], [49] that required (1) one or more of the following symptoms: diarrhea, rectal bleeding, abdominal pain, weight loss, fever or complicated perianal disease; (2) occurrence of symptoms on two or more occasions in the past or ongoing symptoms of at least 4-6 weeks' duration; (3) evidence of inflammation, strictures or fistula from radiological, endoscopic, and histological evaluation (with some specific CD characteristics); (4) exclusion of all other diagnosis besides CD.
###end p 87
###begin p 88
###xml 62 69 62 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t001">Table 1</xref>
###xml 353 360 353 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t001">Table 1</xref>
###xml 440 447 440 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007154-t001">Table 1</xref>
Belgian subjects (referred to as the combined Belgian cohort, Table 1), all of European descent, were used for the exploratory phase of the study and these came from Center 1 (University of Leuven, Belgium) and Center 2 (University of Liege, Belgium). The replication cohorts consisted of Canadian subjects (referred to as the combined Canadian cohort, Table 1), coming from Centers 3 and 4, and Scottish subjects from Edinburgh (Centre 5, Table 1). Center 3 is composed of subjects collected from multiple sites in the province of Quebec (Canada), which are all of European ancestry, and includes 34 probands of Ashkenazi Jewish ancestry and 6 of Sephardic Jewish ancestry. Center 4 includes subjects collected from multiple sites in Toronto (Canada). The vast majority of probands are of European ancestry, including 34 probands of Ashkenazi Jewish ancestry, and 15 probands are of non-European ancestry. Finally, cases and matched controls from Center 5 were collected from multiple sites in Edinburgh (Scotland). The majority of cases are of European ancestry, including 1 case of Jewish ancestry, except for 14 non-European cases and 11 non-European controls. Center 5 will be referred to as the Scottish cohort. Overall, only samples of European origin were included in the analysis.
###end p 88
###begin title 89
Genotyping experiments
###end title 89
###begin p 90
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Bell1">[50]</xref>
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Hsu1">[51]</xref>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Whitcombe1">[52]</xref>
###xml 493 497 493 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 651 659 651 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007154.s007">Table S4</xref>
Single nucleotide polymorphism (SNP) genotyping was performed using either the GenomeLab SNPstream Genotyping System (Beckman Coulter, CA, USA) [50], the fluorescence polarization template-directed dye-terminator (FP-TDI) system (PerkinElmer, MA, USA) [51], or the Taqman 5' exonuclease assay (ABI, CA, USA) (rs2242217: assay C_2394717_20) [52]. Also, since two non-synonymous variants (rs3743930, rs224222) as well as three synonymous variants (rs224225, rs224224, rs224223) were observed in MEFV exon 2 during the sequencing screening phase, genotyping of these variants was done using a sequencing approach. All primers and probes are available in Table S4.
###end p 90
###begin p 91
We used 4 quality checks to determine whether SNPs were reliable and informative: (1) genotyping efficiency (>95%), (2) compliance to Hardy-Weinberg equilibrium (p>0.01), (3) Mendelian inheritance, and (4) population minor allele frequency (>5%).
###end p 91
###begin title 92
Sequencing
###end title 92
###begin p 93
###xml 225 233 225 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007154.s008">Table S5</xref>
###xml 350 354 350 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 356 364 356 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AK096958</italic>
###xml 366 372 366 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF263</italic>
###xml 374 379 374 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIGD7</italic>
###xml 384 390 384 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF75A</italic>
Sequencing was performed on an ABI 3730 DNA Sequencer according to standard protocols. Sequence traces were assembled and analyzed using a modified version of the PolyPhred software package. Primer sequences are available in Table S5. The sequences were compared to the annotated sequences (NCBI Build 36.1, hg18) of 25 exons and promoter regions of MEFV, AK096958, ZNF263, TIGD7 and ZNF75A to identify novel variants.
###end p 93
###begin title 94
Statistical analysis
###end title 94
###begin p 95
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 248 250 248 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D'</italic>
###xml 256 257 256 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 255 257 255 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Barrett2">[53]</xref>
###xml 398 402 398 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007154-Dudbridge1">[54]</xref>
To evaluate MEFV as a candidate gene for IBD, we divided the study into an exploratory and replication phase. Mendelian errors and departures from Hardy-Weinberg equilibrium were assessed using MERLIN v0.9.10. Measures of pairwise LD between SNPs (D' and r2) were computed using Haploview v.4.1 [53]. Tests of association were performed using the likelihood methods implemented in UNPHASED v3.0.10 [54], which can analyze samples of nuclear families, unrelated subjects, or a combination of both. It also allows tests to be conditional on each individual's genotype at one marker to test for association at another, to look for associations that may have been missed due to the possibility of epistasis between two loci. It also tests for the presence of gene-gene interaction (i.e. merely, the departure from log-additive effects of two or more SNPs on the risk). Analysis was done using the default settings; adjustment for Study Center in the combined analysis was done using the options -confounder and -factor; conditional analyses were done using the options -condition and -condgenotype, and gene-by-gene interactions was tested by adding the option -model gxg. To evaluate the significance of our results after correcting for the number of SNPs tested, we used the options -permutation 1000 and -permoutput, and corrected further for the two diseases tested.
###end p 95
###begin title 96
Supporting Information
###end title 96
###begin p 97
###xml 0 130 0 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Linkage disequilibrium structure between tagging SNPs and MEFV exon 2 coding SNPs screened in the combined Belgian IBD sample set.</italic>
###xml 298 300 298 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D'</italic>
###xml 333 334 333 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 332 334 332 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
Linkage disequilibrium structure between tagging SNPs and MEFV exon 2 coding SNPs screened in the combined Belgian IBD sample set. Shown above are the SNPs with their positions in the genes and the LD structure between them. SNPs in red are exonic. The upper left portion of the coloured matrix is D' and the lower right portion is r2. Data for the first SNP is represented on the left column and the bottom row of the matrix.
###end p 97
###begin p 98
(1.61 MB PSD)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
###xml 0 89 0 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conditional tests of association and tests of gene-gene interactions between SNPs in MEFV</italic>
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 151 159 151 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P values</italic>
###xml 296 297 296 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 339 343 339 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 415 420 415 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 501 502 501 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 626 630 626 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 677 681 677 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 706 711 706 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C310S</italic>
###xml 716 721 716 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R202Q</italic>
Conditional tests of association and tests of gene-gene interactions between SNPs in MEFV and in NLRP3 in the combined Belgian-Canadian CD sample set. P values for the tests are color coded and represented. For each combination of SNPs, the upper triangular portions of each square represent the p value for testing the association of the MEFV SNP (horizontal axis) conditional on each individual's genotype at the NLRP3 SNP (vertical axis). The lower triangular portions of each square represent the p value for the test of statistical interaction between the two SNPs. The unconditional tests of association for each SNP in MEFV are shown on the line labeled "none". The two MEFV non-synonymous variants C310S and R202Q are also referred to as rs220379 and rs224222, respectively.
###end p 100
###begin p 101
(0.91 MB TIF)
###end p 101
###begin p 102
Click here for additional data file.
###end p 102
###begin p 103
###xml 0 89 0 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conditional tests of association and tests of gene-gene interactions between SNPs in MEFV</italic>
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLRP3</italic>
###xml 170 179 170 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007154.s002">Figure S2</xref>
Conditional tests of association and tests of gene-gene interactions between SNPs in MEFV and in NLRP3 in the combined Belgian-Canadian UC sample set. Refer to legend of Figure S2.
###end p 103
###begin p 104
(0.95 MB TIF)
###end p 104
###begin p 105
Click here for additional data file.
###end p 105
###begin p 106
Exploratory phase association results of the SNP panel genotyped in the combined Belgian CD and UC trios sample sets.
###end p 106
###begin p 107
(0.11 MB DOC)
###end p 107
###begin p 108
Click here for additional data file.
###end p 108
###begin p 109
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rare variants uncovered in MEFV</italic>
Rare variants uncovered in MEFV exon 2.
###end p 109
###begin p 110
(0.07 MB DOC)
###end p 110
###begin p 111
Click here for additional data file.
###end p 111
###begin p 112
###xml 0 28 0 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Association results of NLRP3</italic>
Association results of NLRP3 tagging SNPs in UC sample sets.
###end p 112
###begin p 113
(0.04 MB DOC)
###end p 113
###begin p 114
Click here for additional data file.
###end p 114
###begin p 115
List of oligos and probes used to perform the genotyping experiments.
###end p 115
###begin p 116
(0.15 MB PDF)
###end p 116
###begin p 117
Click here for additional data file.
###end p 117
###begin p 118
List of oligos used to amplify fragments for the sequencing experiments.
###end p 118
###begin p 119
(0.14 MB DOC)
###end p 119
###begin p 120
Click here for additional data file.
###end p 120
###begin p 121
###xml 23 31 <span type="species:ncbi:9606">patients</span>
We acknowledge the IBD patients and their families for their collaboration. The authors would also like to thank Drs T. Kwan and A. Montpetit for their help in the preparation of this manuscript, as well as J. Stempak, P. Lepage, A. Verner, and the genotyping and sequencing platforms of the McGill University and Genome Quebec Innovation Centre for their technical assistance.
###end p 121
###begin title 122
References
###end title 122
###begin article-title 123
Inflammatory bowel disease.
###end article-title 123
###begin article-title 124
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease.
###end article-title 124
###begin article-title 125
Common variants in the NLRP3 region contribute to Crohn's disease susceptibility.
###end article-title 125
###begin article-title 126
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.
###end article-title 126
###begin article-title 127
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1.
###end article-title 127
###begin article-title 128
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis.
###end article-title 128
###begin article-title 129
Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4.
###end article-title 129
###begin article-title 130
Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility.
###end article-title 130
###begin article-title 131
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.
###end article-title 131
###begin article-title 132
CATERPILLERs, pyrin and hereditary immunological disorders.
###end article-title 132
###begin article-title 133
The infevers autoinflammatory mutation online registry: update with new genes and functions.
###end article-title 133
###begin article-title 134
Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation.
###end article-title 134
###begin article-title 135
NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder.
###end article-title 135
###begin article-title 136
The inflammasome: a danger sensing complex triggering innate immunity.
###end article-title 136
###begin article-title 137
Inflammatory caspases and inflammasomes: master switches of inflammation.
###end article-title 137
###begin article-title 138
The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production.
###end article-title 138
###begin article-title 139
The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment.
###end article-title 139
###begin article-title 140
###xml 66 74 <span type="species:ncbi:9606">patients</span>
The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing.
###end article-title 140
###begin article-title 141
Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16.
###end article-title 141
###begin article-title 142
Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever.
###end article-title 142
###begin article-title 143
A candidate gene for familial Mediterranean fever.
###end article-title 143
###begin article-title 144
Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF).
###end article-title 144
###begin article-title 145
Innate immunity and apoptosis in IBD.
###end article-title 145
###begin article-title 146
A common pathway in periodic fever syndromes.
###end article-title 146
###begin article-title 147
Inflammatory bowel disease in non-Ashkenazi Jews with familial Mediterranean fever.
###end article-title 147
###begin article-title 148
###xml 17 25 <span type="species:ncbi:9606">patients</span>
Crohn disease in patients with familial Mediterranean fever.
###end article-title 148
###begin article-title 149
The familial Mediterranean fever (MEVF) gene as a modifier of Crohn's disease.
###end article-title 149
###begin article-title 150
###xml 85 93 <span type="species:ncbi:9606">patients</span>
Prevalence and significance of mutations in the familial Mediterranean fever gene in patients with Crohn's disease.
###end article-title 150
###begin article-title 151
###xml 112 120 <span type="species:ncbi:9606">patients</span>
Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: evidence for a potential disease-modifying effect?
###end article-title 151
###begin article-title 152
The familial Mediterranean fever (MEFV) gene may be a modifier factor of inflammatory bowel disease in infancy.
###end article-title 152
###begin article-title 153
Efficiency and power in genetic association studies.
###end article-title 153
###begin article-title 154
###xml 51 59 <span type="species:ncbi:9606">patients</span>
The west side story: MEFV haplotype in Spanish FMF patients and controls, and evidence of high LD and a recombination "hot-spot" at the MEFV locus.
###end article-title 154
###begin article-title 155
No gene is an island: the flip-flop phenomenon.
###end article-title 155
###begin article-title 156
Genetic flip-flop without an accompanying change in linkage disequilibrium.
###end article-title 156
###begin article-title 157
Autoinflammatory genes and susceptibility to psoriatic juvenile idiopathic arthritis.
###end article-title 157
###begin article-title 158
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.
###end article-title 158
###begin article-title 159
The genetics and immunopathogenesis of inflammatory bowel disease.
###end article-title 159
###begin article-title 160
Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.
###end article-title 160
###begin article-title 161
Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.
###end article-title 161
###begin article-title 162
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation.
###end article-title 162
###begin article-title 163
###xml 120 125 <span type="species:ncbi:9606">human</span>
Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells.
###end article-title 163
###begin article-title 164
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ECM1</italic>
Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease.
###end article-title 164
###begin article-title 165
Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis.
###end article-title 165
###begin article-title 166
Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
###end article-title 166
###begin article-title 167
A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease.
###end article-title 167
###begin article-title 168
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Antibodies to interleukin 12 abrogate established experimental colitis in mice.
###end article-title 168
###begin article-title 169
###xml 97 101 <span type="species:ncbi:10090">mice</span>
A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.
###end article-title 169
###begin article-title 170
###xml 105 122 <span type="species:ncbi:271">Thermus aquaticus</span>
Detection of specific polymerase chain reaction product by utilizing the 5'-->3' exonuclease activity of Thermus aquaticus DNA polymerase.
###end article-title 170
###begin article-title 171
Classification of inflammatory bowel disease.
###end article-title 171
###begin article-title 172
SNPstream UHT: ultra-high throughput SNP genotyping for pharmacogenomics and drug discovery.
###end article-title 172
###begin article-title 173
Universal SNP genotyping assay with fluorescence polarization detection.
###end article-title 173
###begin article-title 174
A homogeneous fluorescence assay for PCR amplicons: its application to real-time, single-tube genotyping.
###end article-title 174
###begin article-title 175
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 175
###begin article-title 176
Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data.
###end article-title 176
###begin p 177
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 177
###begin p 178
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This research was supported by grants to D.F. from the Canada Foundation for Innovation, the Canada Research Chair program, the Research Institute of the McGill University Health Centre and the Crohn's & Colitis Foundation of Canada (CCFC). A.-C.V. is supported by a PhD training award from the Fonds de la recherche en sante du Quebec. M.S.S. is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (DK624230), the CCFC and the Mount Sinai Hospital Gale and Graham Wright Research Chair in Digestive Diseases. J.D.R. is funded by grants from the National Institutes of Allergy and Infectious Diseases (AI065687 and AI067152), the National Institute of Diabetes and Digestive and Kidney Diseases (DK064869 and DK062432), and the Crohn's and Colitis Foundation of America (SRA512). E.R.N. and J.S. are supported by The Wellcome Trust Programme grant (072789/Z/03/Z). E.L. is a senior research associate at the Belgium Foundation for Scientific Research (FNRS). S.V. is a clinical investigator for the Funds for Scientific Research of Flanders. T.J.H. is the recipient of an Investigator Award from the Ontario Institute for Cancer Research through funding from the Government of Ontario's Ministry of Research and Innovation. D.F. is a senior clinical scientist at the Belgium FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 178

